Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
3
×
national blog main
bristol-myers squibb
cancer
cancer immunotherapy
national
novartis
samit hirawat
boston
boston blog main
boston top stories
brexanalone
clinical data
depression
jeff jonas
major depressive disorder
mental illness
national top stories
neuroscience
phase 3 trial
postpartum depression
psychiatric disorders
sage therapeutics
What
medical
3
×
trial
3
×
acquisition
anniversary
approaches
bn
bristol
celgene
chief
clinical
company’s
corporation
diversity
hirawat
myers
myers’s
officer
pipeline
progress
scrip
spoke
squibb
year
approval
brexanalone
depression
drug
fda
hits
hour
infusion
mark
phase
postpartum
ppd
sage
soon
stock
supervised
surges
Language
unset
Current search:
trial
×
medical
×
" life sciences "
×
@xconomy.com
3 years ago
Bristol Myers’s Hirawat on Pipeline Progress, Clinical Trial Diversity
@xconomy.com
3 years ago
Bristol Myers’s Hirawat on Pipeline Progress, Clinical Trial Diversity
@xconomy.com
5 years ago
Sage Hits Mark in Postpartum Depression Phase 3 Trial, Stock Surges
